These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 17653050

  • 21. Fabrication of resveratrol coated gold nanoparticles and investigation of their effect on diabetic retinopathy in streptozotocin induced diabetic rats.
    Dong Y, Wan G, Yan P, Qian C, Li F, Peng G.
    J Photochem Photobiol B; 2019 Jun; 195():51-57. PubMed ID: 31082734
    [Abstract] [Full Text] [Related]

  • 22. Different expression of vascular endothelial growth factor and pigment epithelium-derived factor between diabetic and non-diabetic epiretinal membranes.
    Nam DH, Oh J, Roh JH, Huh K.
    Ophthalmologica; 2009 Jun; 223(3):188-91. PubMed ID: 19182495
    [Abstract] [Full Text] [Related]

  • 23. Time-dependent expression of PEDF and VEGF in blood serum and retina of rats with oxygen-induced retinopathy.
    Lei CT, Wu XL, Peng J, Chen XF, Qiao LF, Fan YC, Hu JB.
    J Huazhong Univ Sci Technolog Med Sci; 2015 Feb; 35(1):135-139. PubMed ID: 25673207
    [Abstract] [Full Text] [Related]

  • 24. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition.
    Miyamoto K, Khosrof S, Bursell SE, Rohan R, Murata T, Clermont AC, Aiello LP, Ogura Y, Adamis AP.
    Proc Natl Acad Sci U S A; 1999 Sep 14; 96(19):10836-41. PubMed ID: 10485912
    [Abstract] [Full Text] [Related]

  • 25. Silybin reduces obliterated retinal capillaries in experimental diabetic retinopathy in rats.
    Zhang HT, Shi K, Baskota A, Zhou FL, Chen YX, Tian HM.
    Eur J Pharmacol; 2014 Oct 05; 740():233-9. PubMed ID: 25066112
    [Abstract] [Full Text] [Related]

  • 26. Pigment epithelium-derived factor inhibits advanced glycation end-products-induced cytotoxicity in retinal pericytes.
    Sheikpranbabu S, Haribalaganesh R, Gurunathan S.
    Diabetes Metab; 2011 Dec 05; 37(6):505-11. PubMed ID: 21636306
    [Abstract] [Full Text] [Related]

  • 27. Polyethylene glycol-modified pigment epithelial-derived factor: new prospects for treatment of retinal neovascularization.
    Bai YJ, Huang LZ, Xu XL, Du W, Zhou AY, Yu WZ, Li XX.
    J Pharmacol Exp Ther; 2012 Jul 05; 342(1):131-9. PubMed ID: 22495066
    [Abstract] [Full Text] [Related]

  • 28. PlGF silencing combined with PEDF overexpression: Modeling RPE secretion as potential therapy for retinal neovascularization.
    Araújo RS, Silva GA.
    Mol Biol Rep; 2020 Jun 05; 47(6):4413-4425. PubMed ID: 32385771
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
    Cui B, Sun JH, Xiang FF, Liu L, Li WJ.
    Exp Eye Res; 2012 May 05; 98():37-43. PubMed ID: 22449442
    [Abstract] [Full Text] [Related]

  • 31. Effect of pigment epithelium derived factor on the expression of glutamine synthetase in early phase of experimental diabetic retinopathy.
    Shen X, Xie B, Cheng Y, Jiao Q, Zhong Y.
    Ocul Immunol Inflamm; 2011 Aug 05; 19(4):246-54. PubMed ID: 21770802
    [Abstract] [Full Text] [Related]

  • 32. Elevated pigment epithelium-derived factor induces diabetic erectile dysfunction via interruption of the Akt/Hsp90β/eNOS complex.
    Che D, Fang Z, Yan L, Du J, Li F, Xie J, Feng J, Yin P, Qi W, Yang Z, Ma J, Yang X, Gao G, Zhou T.
    Diabetologia; 2020 Sep 05; 63(9):1857-1871. PubMed ID: 32377760
    [Abstract] [Full Text] [Related]

  • 33. [The protective effect of pigment epithelial-derived factor modified human umbilical cord mesenchymal stem cells on rats with diabetic retinopathy].
    Zhang W, Duan HT, Chen S, Wang YX, Kong JH, Dong M, Bi X, Song J.
    Zhonghua Yan Ke Za Zhi; 2017 Jul 11; 53(7):540-547. PubMed ID: 28728289
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis.
    Duh EJ, Yang HS, Haller JA, De Juan E, Humayun MS, Gehlbach P, Melia M, Pieramici D, Harlan JB, Campochiaro PA, Zack DJ.
    Am J Ophthalmol; 2004 Apr 11; 137(4):668-74. PubMed ID: 15059706
    [Abstract] [Full Text] [Related]

  • 36. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
    Kaji Y, Usui T, Ishida S, Yamashiro K, Moore TC, Moore J, Yamamoto Y, Yamamoto H, Adamis AP.
    Invest Ophthalmol Vis Sci; 2007 Feb 11; 48(2):858-65. PubMed ID: 17251488
    [Abstract] [Full Text] [Related]

  • 37. pEPito-driven PEDF Expression Ameliorates Diabetic Retinopathy Hallmarks.
    Calado SM, Diaz-Corrales F, Silva GA.
    Hum Gene Ther Methods; 2016 Apr 11; 27(2):79-86. PubMed ID: 26942449
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Expression of pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in sickle cell retina and choroid.
    Kim SY, Mocanu C, Mcleod DS, Bhutto IA, Merges C, Eid M, Tong P, Lutty GA.
    Exp Eye Res; 2003 Oct 11; 77(4):433-45. PubMed ID: 12957143
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.